Form 8-K - Current report:
SEC Accession No. 0001193125-24-251274
Filing Date
2024-11-05
Accepted
2024-11-05 16:30:25
Documents
2
Period of Report
2024-10-30
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d852268d8k.htm 8-K 26777
2 EX-99.1 d852268dex991.htm EX-99.1 72712
  Complete submission text file 0001193125-24-251274.txt   100707
Mailing Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Acquisition Corp. III Life Sciences (Filer) CIK: 0002029769 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42383 | Film No.: 241427952
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)